Advanced in Ulcerative Colitis

Dr. Peter L. Moses

Gastroenterology
111 Colchester Ave, Acc 5th Floor Surgery Clinic Main, Fahc, 
Burlington, VT 
Advanced in Ulcerative Colitis
111 Colchester Ave, Acc 5th Floor Surgery Clinic Main, Fahc, 
Burlington, VT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Peter Moses is a Gastroenterologist in Burlington, Vermont. Dr. Moses is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Ulcerative Colitis, Hemorrhagic Proctocolitis, Colitis, Viral Gastroenteritis, and Endoscopy.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 4 clinical trials in the study of Ulcerative Colitis.

Specialties
Gastroenterology
Licenses
Internal Medicine in VT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
MVP Health
  • EPO
  • PPO

Locations

111 Colchester Ave, Acc 5th Floor Surgery Clinic Main, Fahc, Burlington, VT 05401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis
Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis
Enrollment Status: Unknown
Publish Date: July 09, 2018
Intervention Type: Biological
Study Drug: Fecal Microbiota Transplant
Study Phase: Early Phase 1
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

15 Total Publications

Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease.
Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease.
Journal: mSystems
Published: November 09, 2023
Similar Doctors
Distinguished in Ulcerative Colitis
Dr. Alex John
Gastroenterology
Distinguished in Ulcerative Colitis
Dr. Alex John
Gastroenterology
875 Roosevelt Hwy, Suite 132, 
Colchester, VT 
 (2.5 miles away)
802-864-7483
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alex John is a Gastroenterologist in Colchester, Vermont. Dr. John is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Ulcerative Colitis, Diarrhea, Trichohepatoenteric Syndrome, and Crohn's Disease. Dr. John is currently accepting new patients.

Advanced in Ulcerative Colitis
Dr. Nicholas Ferrentino
Gastroenterology
Advanced in Ulcerative Colitis
Dr. Nicholas Ferrentino
Gastroenterology

University Of Vermont Medical Center Inc

1 S Prospect St, 
Burlington, VT 
 (0.4 miles away)
802-847-0000
Languages Spoken:
English
See accepted insurances

Nicholas Ferrentino is a Gastroenterologist in Burlington, Vermont. Dr. Ferrentino is rated as a Distinguished provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Visceromegaly, Alcoholic Cirrhosis, Cirrhosis, Endoscopy, and Gastrectomy.

Advanced in Ulcerative Colitis
Dr. Doris Strader
Gastroenterology
Advanced in Ulcerative Colitis
Dr. Doris Strader
Gastroenterology
111 Colchester Ave, Smith 247a, 
Burlington, VT 
 (0.1 miles away)
802-847-2554
Languages Spoken:
English
See accepted insurances

Doris Strader is a Gastroenterologist in Burlington, Vermont. Dr. Strader is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. Her top areas of expertise are Bowel Incontinence, Encopresis, Hepatitis, Endoscopy, and Gastrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moses's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile